Oligonucleotide Therapeutics

Regular price €113.99
Quantity:
In stock with our UK publisher. 14-28 days
Delivery/Collection within 10-20 working days
14 days return policy Shipping & Delivery
advanced
annals
available
basic
books
Category=PSD
chapters
concentrates
data
drug
eq_bestseller
eq_isMigrated=1
eq_isMigrated=2
eq_nobargain
eq_non-fiction
eq_science
field
individual
institutional
journal
leaders
mechanisms
oligonucleotide
oligonucleotidebased
relevant
sale
stages
subscriptions
volume
volumes

Product details

  • ISBN 9781573315876
  • Weight: 318g
  • Dimensions: 152 x 229mm
  • Publication Date: 11 Dec 2006
  • Publisher: John Wiley and Sons Ltd
  • Publication City/Country: GB
  • Product Form: Paperback
Secure checkout Fast Shipping Easy returns
This volume concentrates on the most relevant oligonucleotide research and drug development areas and emphasizes the basic mechanisms and biology of oligonucleotide reagents.

Chapters are devoted to RNAi, oligonucleotide delivery, and immunomodulation. Because of the advanced stages of oligonucleotide-based drug development, preclinical and clinical data are also presented by leaders in the field.

NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit www.blackwellpublishing.com/nyas.

ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to the Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member

Thomas Tuschl is a German biochemist and molecular biologist, known for his research on RNA. John J. Rossi is the editor of Oligonucleotide Therapeutics: First Annual Meetingof the Oligonucleotide Therapeutics Society, Volume 1082, published by Wiley.